#United States #IceCure Medical #ProSense® #Fairhope #Thomas Hospital

IceCure Medical Introduces ProSense® Cryoablation Technology at Thomas Hospital

In a groundbreaking development for breast cancer treatment in Alabama, IceCure Medical Ltd. has announced the installation of its ProSense® system at Thomas Hospital, part of the Infirmary Health network. This facility now stands as the first hospital in Alabama to offer cryoablation, a minimally invasive option designed to treat low-risk breast cancer by freezing tumors instead of traditional surgical methods.

Pioneering Frozen Solutions

The announcement comes shortly after IceCure received FDA marketing authorization for ProSense® in treating low-risk breast cancer, specifically aimed at women aged 70 and older. This new technique offers a less invasive alternative that aligns with the evolving standards of breast cancer care. Dr. Katelin Holmes, a certified breast surgeon and Medical Director of Breast Surgical Services at Thomas Hospital, will oversee the selection of patients for the cryoablation procedure, with treatments slated to begin imminently.

Shad Good, IceCure's Vice President of Sales for North America, stated, “We are excited that Thomas Hospital is pioneering this innovative treatment in Alabama. With ProSense®, they will offer the first cryoablation procedures for breast cancer in the state, which is a significant advancement for breast care in the region.” This announcement signals a growing interest in minimally invasive treatments, particularly as awareness increases following recent FDA clearances.

Support from Local Philanthropy

The acquisition of the ProSense® system was made possible through the generous support of the Thomas Hospital Foundation. As a nonprofit organization, the Foundation is dedicated to enhancing patient care by providing access to advanced medical technologies. Nathan Payne, Director of the Foundation, emphasized the importance of this initiative: “Bringing cutting-edge treatment options to our community is a vital part of our mission. We are thrilled to invest in technologies like ProSense® that can significantly impact patient outcomes.”

The ProSense® system uses liquid nitrogen to create large lethal zones around tumors, maximizing its effectiveness in treating both benign and malignant lesions across various organs, including the breast, kidney, lung, and liver. Its design not only allows for quick and efficient procedures but also fosters a comfortable environment for patients during treatment.

Advantages of Cryoablation

Cryoablation with ProSense® enhances patient outcomes by facilitating faster recovery times, minimizing pain, and reducing the risks often associated with conventional surgeries. This innovative tool is engineered for efficiency, making it suitable for use in outpatient settings, which adds another layer of convenience for patients who might otherwise face lengthy recovery times after traditional surgeries.

For those interested in breast cancer treatment options in Alabama, IceCure's ProSense® represents a new chapter in care that prioritizes patient comfort and effective treatment methods. The introduction of this technology at Thomas Hospital could potentially set a precedent for other facilities across the state and beyond, as they observe the success and patient feedback following cryoablation procedures.

Looking Ahead

IceCure Medical is steadfast in its commitment to advancing cryoablation technology. Since its inception, the company has focused on developing safe and effective ways to treat tumors, with their primary areas of concentration being breast, kidney, bone, and lung cancers. As the ProSense® system gains traction and showcases its benefits through patient experiences at Thomas Hospital, IceCure is optimistic about expanding its reach and helping more women access this innovative treatment.

With a reliable path forward indicated by local endorsements and philanthropic commitments, the future of breast cancer treatment in Alabama looks promising. The collective effort of medical practitioners, hospital administrations, and health organizations like the Thomas Hospital Foundation reflects a strong dedication to providing advanced care to communities in need. For more updates on ProSense® and its impact, stay tuned as more procedures are expected to commence in the coming weeks.